Cellectar Latest Filings
Event
03/17/2025
Form 8-K - Current report
Item 5.03: Amendments to Corporate Charters
Item 5.02: Changes in Executive Management
03/13/2025
Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript
Event
03/13/2025
Form 8-K - Current report
Report Period: Q4' FY2024
Financial Results:
: revenue $0.00, estimate $0.00, prior $0.00;
: EPS $-0.07, concensus $-0.35, prior $-3.11
Interim
03/13/2025
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Ownership
03/12/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
02/18/2025
Form 4 - Statement of changes in beneficial ownership of securities
Show More Filings
